Researchers from Brown University and the University of California San Francisco have said that epigenetic changes to DNA in breast cancers are directly linked with diet, alcohol, and tumour size, and could hence give a glimpse of the severity of the disease.
The findings point to the emergence of new biomarkers that researchers hope will give a more detailed view of the environmental factors that contribute to tumour development and could, in the future, provide improvements in diagnostics and treatment decisions, as well as potentially more personalized recommendations to help prevent recurrence.
The use of epigenetic profiles as biomarkers of disease subtype and severity is a rapidly emerging field with other notable contributions from this group- a field that is being advanced with the support of the NIH, and shows promise for developing novel clinical tools.
The study measured epigenetic profiles in stage I to IV breast tumors from 162 women enrolled in the Pathways Study, a study of breast cancer survivorship based at Kaiser Permanente of Northern California.
The researchers took a detailed assessment of an individual's demographic and dietary information, as well as breast cancer tumour characteristics.
The study's data show the promise of tumour epigenetic signatures to provide more detailed tumour staging, and eventually prediction of prognosis. In particular, the study found that alcohol consumption, folate intake (vitamin B9), and tumour size are each independently associated with epigenetic profiles of tumours.
"By investigating epigenetic patterns in tumours from patients we have extensive lifestyle data on, we are helping to bridge the gap between environmental research and translational research," said Karl Kelsey, a contributing author on the study.
Epigenetics refers to the control of patterns of gene expression in cells, which give rise to the necessary differences responsible for creating the complex and interacting tissues in the body.
"This study provides a new window for finding environmental links to breast disease. Our work indicates that we will soon have new ways to monitor and assess lifestyle and environmental factors for breast cancer," said John Wiencke, senior author of the paper.
The study is published in today's edition of PLoS Genetics.